IDEX Corporation filings document formal disclosures for an NYSE-listed engineered products company with common stock trading under IEX. Recent 8-K reports furnish quarterly and annual operating results, press-release exhibits, share repurchase authorization, capital-return activity, and executive officer changes.
The company’s proxy and annual meeting filings cover board elections, advisory executive compensation votes, auditor ratification, and related governance disclosures. Its filings also identify registered common stock, Inline XBRL cover-page data, exhibit filings, and material-event reporting tied to financial condition, leadership, shareholder votes, and capital allocation.
IDEX Corporation is reported to be 2.34% beneficially owned by affiliates of Wellington Management Group LLP as shown on an amended Schedule 13G/A. The filing lists 1,738,531 shares as shared dispositive power and shows shared voting power of 1,597,417 as of 03/31/2026.
The filing identifies Wellington Investment Advisors Holdings LLP, Wellington Group Holdings LLP and Wellington Management Group LLP as reporting persons and states the shares are owned of record by clients of the Wellington investment advisers. The signatures are dated 05/15/2026.
IDEX Corp CEO and President Eric D. Ashleman reported an option exercise and share sales. On May 11, 2026, he exercised options for 15,385 shares of common stock at an exercise price of $93.27 per share. The same day, he completed two open-market sales totaling 15,385 shares of common stock, selling 4,915 shares at a weighted average price of $215.8115 and 10,470 shares at $214.9457, with each trade executed in multiple transactions within stated price ranges. Following these transactions, he directly owned 66,658 shares of IDEX common stock.
Watts Stanfield Paris reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Stanfield Paris Watts received an equity award of 805 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of IDEX common stock. Following this grant, the director holds 4,195 shares of common stock.
The RSUs vest in full on the earlier of May 6, 2027, or the date of IDEX’s next annual stockholders meeting, if that meeting occurs at least 50 weeks after the prior year’s meeting. Vesting is conditioned on the director’s continuous service through the vesting date.
Quiroz Alejandro reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Alejandro Quiroz reported an equity award of 805 shares of common stock, received as a grant of restricted stock units (RSUs). Each RSU represents a right to receive one share of IDEX common stock if vesting conditions are met.
The RSUs vest in full on the earlier of May 6, 2027, or the date of the next annual stockholders meeting, provided that meeting occurs at least 50 weeks after the prior year’s meeting and Quiroz remains in continuous service through that date. Following this award, he directly holds 4,030 shares of common stock.
IDEX CORP director Katrina L. Helmkamp received an equity award of 1,035 shares of common stock in the form of restricted stock units. The award was granted at a price of $0.00 per share as compensation, not as an open-market purchase.
After this grant, Helmkamp directly holds 14,235 shares of IDEX common stock. Each RSU converts into one share of common stock and vests in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, provided that meeting occurs at least 50 weeks after the prior year’s meeting and she remains in continuous service through the vesting date.
Gunter Lakecia N reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Lakecia N. Gunter received an equity award of 805 shares of common stock on May 6, 2026. The award is in the form of restricted stock units, each representing a contingent right to one share of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, if that meeting occurs at least 50 weeks after the prior year’s meeting, and only if Gunter continues in service through the vesting date. After this grant, Gunter directly holds 4,925 shares of IDEX common stock.
IDEX Corp director Matthijs Glastra received a stock-based award. On May 6, 2026, he acquired 805 shares of common stock through a grant of restricted stock units at no cash cost, increasing his direct holdings to 1,880 shares. These RSUs vest in full on May 6, 2027 or at the next annual stockholders meeting held at least 50 weeks after the prior year's meeting, contingent on his continuous service.
Disher Stephanie reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Stephanie Disher received an equity award in the form of restricted stock units. On May 6, 2026, she was granted 805 RSUs, each representing a contingent right to receive one share of IDEX common stock at no purchase price.
These RSUs vest in full on May 6, 2027, or on the date of the company’s next annual stockholders meeting if that meeting occurs at least 50 weeks after the prior year’s meeting, subject to her continuous service. Following this award, she holds 1,880 shares of common stock directly.
IDEX CORP director Carl R. Christenson received an equity award of 805 shares of common stock in the form of restricted stock units. These RSUs convert into one share each when they vest. Following this grant, he directly holds 7,156 shares of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027, or the date of the company’s next annual stockholders meeting if it occurs at least 50 weeks after the prior year’s meeting, assuming he continues in service through the vesting date.